CRB Monitor Securities Database Updates
During the week of July 25 - 31, 2022, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of July 25 - 31, 2022:
Tier |
Total # |
Active / Inactive |
Added |
Removed |
Net Change |
Tier 1A |
148 |
125 / 21 / 2 |
+0 | -0 | +0 |
Tier 1B |
720 |
590 / 127 / 3 |
+0 | -0 | +0 |
Tier 2 |
365 |
339 / 22 / 4 |
+1 | -1 | +0 |
Tier 3 |
569 |
542 / 26 / 1 |
+0 | -0 | +0 |
Total Issuances |
1,802 |
1,596 / 196 / 10 |
+1 | -1 | +0 |
Total Issuers (w/o Pre-IPOs) |
1,400 |
- |
+1 | -1 | +0 |
Total Issuers (w/ Pre-IPOs) |
1,410 |
- |
+1 | -1 | +0 |
- Added 1 Tier 2 Security & Removed 1 Tier 2 Security:
- +1 = New CRB (“Ambari Brands Inc.”)
- -1 = Removed CRB from Database (“Choice Consolidation Corp.”)
- Rationale = Choice Consolidation Corp., a Special Purpose Acquisition Corporation (SPAC), announced that its board of directors has determined that the Company will be wound-up as they do not believe that an appropriate qualifying transaction can be identified and completed within the Company’s permitted timeline. "While the creation of the legal and regulated cannabis industry presents the opportunity to harness growth potential of a burgeoning industry, the current shifting market conditions and partisan political gridlock have made our current pathway too unpredictable. After careful review and consideration, we believe it is in the best interest of our shareholders to return their investments at a time when it can be better deployed in other vehicles."
- +1 = New CRB (“Ambari Brands Inc.”)
All newly-identified CRBs during the week:
Company Name |
Tier |
Pure-Play | Sector |
Description |
(CSE: AMB) |
2 | Yes | Personal Products |
Ambari Brands Inc. is a luxury skincare and consumer brand company developing a line of products which combines high levels of active ingredients, smart adaptogens and broad-spectrum CBD. Ambari's products use organically-grown, broad-spectrum CBD. Per its own admission, "The Company currently derives, and is expected to continue to derive, a portion of its revenues from the production and distribution of Hemp-infused skincare products in certain states in the United States." |